Open menu
Paytm Money logo
Download App
UTI Mutual Fund

UTI Healthcare Fund Direct-Growth

NAV
returns change indicator
85.1671
as on 21 May 2019 09:15 PM
-0.0224(0.03%)
Last Change
Scheme Ratings
medal
3
Pharma
by returns in last 5 years
Schemes Managed By
Investment Performance
would have given a returns of
110,871
star
121,647
star
92,333
star
95,063
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
4,937
Profit (absolute return)
4.94%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money
Investment Returns
In the last 3 months
1.29%
In the last 6 months
5.09%
In the last 1 year
3.93%
In the last 3 years
4.94%
In the last 5 years
43.68%
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk
Scheme Information
UTI Healthcare Fund Direct-Growth
UTI Healthcare Fund Direct-Growth
as of 21 May 2019 09:15 PM
436.87 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed less than 1 year
1.60%
Expense Ratio
Plan
Growth
4.03%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed less than 1 year
Scheme Document
Sectors Holding in this Mutual Fund
as on 30 Apr 2019
Sort By
Healthcare
94.79%
414.11 Cr
Cash Holding
4.03%
17.61 Cr
Financial
2.61%
11.40 Cr
Sectors Holding in this Mutual Fund
as on 30 Apr 2019
Sort By
Healthcare
94.79%
414.11 Cr
Cash Holding
4.03%
17.61 Cr
Financial
2.61%
11.40 Cr
Companies Holding in this Mutual Fund
as on 30 Apr 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
14.41%
62.95 Cr
Divi's Laboratories Ltd.
9.32%
40.72 Cr
Lupin Ltd.
8.15%
35.61 Cr
Ipca Laboratories Ltd.
7.25%
31.67 Cr
Cadila Healthcare Ltd.
6.04%
26.39 Cr
Dr. Reddy's Laboratories Ltd.
5.99%
26.17 Cr
Cipla Ltd.
5.98%
26.12 Cr
Sanofi India Ltd.
5.98%
26.12 Cr
Torrent Pharmaceuticals Ltd.
4.41%
19.27 Cr
Pfizer Ltd.
4.30%
18.79 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 30 Apr 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
14.41%
62.95 Cr
Divi's Laboratories Ltd.
9.32%
40.72 Cr
Lupin Ltd.
8.15%
35.61 Cr
Ipca Laboratories Ltd.
7.25%
31.67 Cr
Cadila Healthcare Ltd.
6.04%
26.39 Cr
Dr. Reddy's Laboratories Ltd.
5.99%
26.17 Cr
Cipla Ltd.
5.98%
26.12 Cr
Sanofi India Ltd.
5.98%
26.12 Cr
Torrent Pharmaceuticals Ltd.
4.41%
19.27 Cr
Pfizer Ltd.
4.30%
18.79 Cr
View All
View All
About UTI Healthcare Fund Direct-Growth
UTI Healthcare Fund Direct-Growth is a Equity mutual fund scheme from UTI Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager V Srivatsa. It has an AUM of ₹436.87 Crores and the latest NAV decalared is ₹85.167 as on 21 May 2019 at 9:15 pm.
UTI Healthcare Fund Direct-Growth scheme return performance in last 1 year is 3.93%, in last 3 years is -4.94% and 78.47% since scheme launch. The min. SIP amount to invest in this scheme is ₹500.
Scheme Objective
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
AMC Information
UTI Mutual Fund
UTI Mutual Fund
View AMC Details
157,722.60 Cr
AUM
200
Schemes
Address
Address
UTI Tower, 'GN' Block,Bandra-Kurla Complex,Bandra (East),400051
Phone Number
Phone Number
Phone : 022- 6678 6666, 66786354/ 1800 22 1230
Fax : (022) 26523031